Chapel Hill, NC, United States of America

Robert V Skibbens


Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (1993 - 2000)
  • Brookline, MA (US) (2001)

Company Filing History:


Years Active: 1993-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Robert V Skibbens

Introduction

Robert V Skibbens is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of immunology through his innovative work on monoclonal antibodies. With a total of five patents to his name, Skibbens has established himself as a key figure in the development of tools for studying the immune system.

Latest Patents

Skibbens' latest patents focus on monoclonal antibodies that are reactive with defined regions of the T cell antigen receptor (TCR). One of his inventions provides monoclonal antibodies that recognize a constant region of the alpha chain of the TCR. Specifically, he has developed two monoclonal antibodies, termed αF1 and αF2, which react with different epitopes on the framework region of the alpha monomer of the TCR molecule. Additionally, he has created monoclonal antibodies that target variable regions of the beta chain of the TCR, including W112 and 2D1, which react with β chain variable regions Vβ5.3 and Vβ8.1, respectively. Furthermore, he has developed monoclonal antibody δTCS1, isotype IgG2a, which is reactive with a variable region of the delta chain of the TCR. These monoclonal antibodies have significant value in diagnosis and therapy, serving as useful tools for the study of the immune system.

Career Highlights

Throughout his career, Skibbens has worked with prominent companies such as Astra Ab and T Cell Sciences, Inc. His work has been instrumental in advancing the understanding of T cell receptors and their applications in medical science.

Collaborations

Some of his notable coworkers include Larry D Henry and Charles William Rittershaus. Their collaborative efforts have contributed to the success of Skibbens' research and innovations.

Conclusion

Robert V Skibbens is a distinguished inventor whose work on monoclonal antibodies has made a lasting impact in the field of immunology. His innovative contributions continue to enhance the understanding and treatment of immune-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…